Split Congress Makes Comprehensive Drug Pricing Bill Unlikely

Drug pricing legislation may be in for another couple years of slow progress due to the likelihood of a divided Congress, though the drug industry might still be targeted for offsets with one-off measures that don’t constitute comprehensive drug pricing bills. At press time, Democrats will lead the House and Republicans are favored to keep control of the Senate. The current tally is 48 to 48 in the Senate, but the GOP is favored in the four remaining races, two...